You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma, Large B-Cell, Diffuse

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Large Cell Lymphoma, Diffuse, Relapsed Cancer, Refractory Cancer Trial (AutoSCT, GDP, Epcoritamab)

Not yet recruiting
  • Large Cell Lymphoma, Diffuse
  • +2 more
  • AutoSCT
  • +2 more
  • (no location specified)
May 10, 2023

Breast Cancer, Lymphoma, Large B-Cell, Diffuse, Cardiotoxicity Trial in Rozzano (Nebivolol, Placebo)

Active, not recruiting
  • Breast Cancer
  • +4 more
  • Rozzano, Milan, Italy
    IRCCS Humanitas Research Hospital
Feb 5, 2023

Diffuse Large B Cell Lymphoma Trial (Pembrolizumab, Rituximab, Ifosfamide)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Headington, Oxford, United Kingdom
  • +1 more
Nov 2, 2022

Diffuse Large B-cell Lymphoma Trial in Shanghai (Rituximab, Cyclophosphamide, Epirubicin)

Active, not recruiting
  • Diffuse Large B-cell Lymphoma
  • Shanghai, Shanghai, China
    Shanghai Ruijin Hospital
Dec 1, 2022

Diffuse Large B Cell Lymphoma Trial (Bridging Radiotherapy)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Bridging Radiotherapy
  • Leeds, United Kingdom
  • +2 more
Dec 6, 2022

Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (Pirtobrutinib, LV20.19 CAR T cells)

Not yet recruiting
  • Non Hodgkin Lymphoma
  • +5 more
  • (no location specified)
Aug 4, 2023

Diffuse Large B Cell Lymphoma Trial in Suzhou (Rituximab, Orelabrutinib, Pomalidomide)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Apr 10, 2023

Orelabrutinib in Combination With Standard Treatment Regimen for

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse Neoplasms by Histologic Type
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Aug 23, 2023

Diffuse Large B Cell Lymphoma, DLBCL, Cancer Trial in Madison (Rituximab, Cyclophosphamide, Doxorubicin)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Dec 12, 2022

Large B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Homburg (R-miniCHOP + Acalabrutinib, R-miniCHOP)

Not yet recruiting
  • Large B-cell Lymphoma
  • Diffuse Large B Cell Lymphoma
  • Homburg, Saarland, Germany
    Saarland University Medical Center
Apr 19, 2023

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell Trial in United Kingdom (ALETA-001)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • +4 more
  • Birmingham, United Kingdom
  • +5 more
Sep 18, 2023

Diffuse Large B-cell Lymphoma Trial in Tampa, Philadelphia (Tisagenlecleucel, Ibrutinib)

Terminated
  • Diffuse Large B-cell Lymphoma
  • Tampa, Florida
  • +1 more
Jan 27, 2023

Diffuse Large B-cell Lymphoma (DLBCL) Trial in Westbury (Odronextamab, Rituximab, Cyclophosphamide)

Recruiting
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Westbury, New York
    Clinical Research Alliance Inc
Oct 13, 2023

Diffuse Large B Cell Lymphoma Trial (Venetoclax, Carmustine, Cytarabine)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
May 9, 2023

The First Affiliated Hospital of Nanchang University Trial in Nanchang, Jinan (Orelabrutinib+R-CHOP)

Recruiting
  • The First Affiliated Hospital of Nanchang University
  • Nanchang, Jiangxi, China
  • +1 more
Jul 3, 2023

Diffuse Large B-cell Lymphoma Trial in Hangzhou (Metabolically Armed CD19 CAR-T cells)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Metabolically Armed CD19 CAR-T cells
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Nov 1, 2023

Diffuse Large B Cell Lymphoma Trial in Shenyang (Zanubrutinib, Rituximab, Cyclophosphamide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Shenyang, Liaoning, China
    Xing Xiaojing
Jun 1, 2023

Diffuse Large B Cell Lymphoma Trial in Wuhan (Zanubrutinib plus RCHOP)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib plus RCHOP
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 16, 2023

Including miRNA-based Tumor Signatures in Diffuse Large B Cell

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Relapsed Non-Hodgkin Lymphoma
  • no intervention (observational study)
  • Napoli, Italy
  • +2 more
Feb 17, 2023

Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

Not yet recruiting
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
  • +5 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2023

Diffuse Large B-cell Lymphoma Trial in Wuhan (Mitoxantrone Hydrochloride Liposome, Rituximab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome
  • +2 more
  • Wuhan, Hubei, China
    Department of Hematology Tongji Hospital, Tongji Medical College
Oct 7, 2022

Tafasitamab in Combination With Lenalidomide in Patients withR/R

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Tafasitamab Injection
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
May 31, 2023

Diffuse Large B Cell Lymphoma, CAR-T, Radiotherapy Trial (ultra-fraction radiotherapy)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • ultra-fraction radiotherapy
  • (no location specified)
Aug 22, 2022

Diffuse Large B-cell Lymphoma Trial in Hangzhou, Ningbo (CD19-7×19 CAR-T combined with Tislelizumab)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • CD19-7×19 CAR-T combined with Tislelizumab
  • Hangzhou, Zhejiang, China
  • +1 more
Dec 12, 2022

People Living With HIV Treated With CD19-directed CAR T Cell

Active, not recruiting
  • Leukemia
  • +9 more
    • Philadelphia, Pennsylvania
      Pennsylvania Hospital
    Mar 29, 2023